Hörkkö S - Search Results

1

1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma.

Ala-Korpela M, Korhonen A, Keisala J, Hörkkö S, Korpi P, Ingman LP, Jokisaari J, Savolainen MJ, Kesäniemi YA. Ala-Korpela M, et al. Among authors: horkko s. J Lipid Res. 1994 Dec;35(12):2292-304. J Lipid Res. 1994. PMID: 7897326 Free article.

2

Low-density lipoprotein clearance in patients with chronic renal failure.

Kastarinen H, Hörkkö S, Kauma H, Karjalainen A, Savolainen MJ, Kesäniemi YA. Kastarinen H, et al. Among authors: horkko s. Nephrol Dial Transplant. 2009 Jul;24(7):2131-5. doi: 10.1093/ndt/gfp026. Epub 2009 Feb 5. Nephrol Dial Transplant. 2009. PMID: 19196823

3

Carbamylation-induced alterations in low-density lipoprotein metabolism.

Hörkkö S, Savolainen MJ, Kervinen K, Kesäniemi YA. Hörkkö S, et al. Kidney Int. 1992 May;41(5):1175-81. doi: 10.1038/ki.1992.179. Kidney Int. 1992. PMID: 1319520 Free article.

4

Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment.

Hörkkö S, Huttunen K, Kesäniemi YA. Hörkkö S, et al. Kidney Int. 1995 Jun;47(6):1732-40. doi: 10.1038/ki.1995.239. Kidney Int. 1995. PMID: 7643543 Free article.

5

Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients.

Hörkkö S, Huttunen K, Läärä E, Kervinen K, Kesäniemi YA. Hörkkö S, et al. Ann Med. 1994 Aug;26(4):271-82. doi: 10.3109/07853899409147902. Ann Med. 1994. PMID: 7946245 Clinical Trial.

6

Decreased clearance of low-density lipoprotein in patients with chronic renal failure.

Hörkkö S, Huttunen K, Korhonen T, Kesäniemi YA. Hörkkö S, et al. Kidney Int. 1994 Feb;45(2):561-70. doi: 10.1038/ki.1994.73. Kidney Int. 1994. PMID: 8164446 Free article.

7

Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein.

Hörkkö S, Huttunen K, Kervinen K, Kesäniemi YA. Hörkkö S, et al. Eur J Clin Invest. 1994 Feb;24(2):105-13. doi: 10.1111/j.1365-2362.1994.tb00974.x. Eur J Clin Invest. 1994. PMID: 8206079

8

Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a).

Silaste ML, Rantala M, Alfthan G, Aro A, Witztum JL, Kesäniemi YA, Hörkkö S. Silaste ML, et al. Among authors: horkko s. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):498-503. doi: 10.1161/01.ATV.0000118012.64932.f4. Epub 2004 Jan 22. Arterioscler Thromb Vasc Biol. 2004. PMID: 14739118

9

Estrogen replacement therapy increases plasma ghrelin levels.

Kellokoski E, Pöykkö SM, Karjalainen AH, Ukkola O, Heikkinen J, Kesäniemi YA, Hörkkö S. Kellokoski E, et al. Among authors: horkko s. J Clin Endocrinol Metab. 2005 May;90(5):2954-63. doi: 10.1210/jc.2004-2016. Epub 2005 Feb 15. J Clin Endocrinol Metab. 2005. PMID: 15872336 Clinical Trial.

10

Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation.

Silaste ML, Alfthan G, Aro A, Kesäniemi YA, Hörkkö S. Silaste ML, et al. Among authors: horkko s. Br J Nutr. 2007 Dec;98(6):1251-8. doi: 10.1017/S0007114507787445. Epub 2007 Jul 9. Br J Nutr. 2007. PMID: 17617941 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page